Tizanidne Hydrochloride Capsule
Product Images NDC 72162-1861

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 72162-1861). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621861)

This is a pharmaceutical label for capsules containing 4.58 mg of Tizanidine Hydrochloride, equivalent to 4 mg of Tizanidine base. The NDC number is 72162-1861-2, and the prescription should be kept out of reach of children. The capsules should be stored at 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication should be dispensed in tight containers with child-resistant closures. This product is not interchangeable with tizanidine tablets or Zanaflex® tablets. For more information and instructions, refer to the provided link.*

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

This data appears to show the improvement in Ashworth Score over time after taking different doses of tizanidine and placebo. The chart or graph likely displays how the Ashworth Score changes in hours post-dose for each treatment group.*

FDA Label Image

Tiz04 (Tiz04)

This text provides data on the improvement in Ashworth Score with the use of tizanidine at a mean dose of 26.8 mg. It includes information on the titration process, the end of maintenance at Study Week 7, and the endpoint analysis using the Last Observation Carried Forward method.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.